Glaukos has claimed a series of regulatory clearances in Europe for its micro-scale surgical implants to treat patients with glaucoma, expanding the company’s reach overseas. The green lights under ...
FDA has announced it has approved the first glaucoma stent for use with cataract surgery, according to a news release. The iStent Trabecular Micro-Bypass Stent System, model GTS100R/L, manufactured by ...
Efficacy is higher for the Xen 45 gel stent implant as a standalone procedure than combined with cataract surgery. The Xen 45 gel stent implant provides effective, long-term treatment for open-angle ...
While the Xen 45 gel stent implant showed beneficial long-term outcomes for the treatment of open-angle glaucoma, a substantial proportion of patients needed follow-up operations or bleb needling, ...
Worldwide, more than one million trabecular microbypass stents have been implanted in combination with cataract surgery. Despite glaucoma medications and prior microbypass stenting, target IOP may no ...
Please provide your email address to receive an email when new articles are posted on . George Reiss, MD, and colleagues sought to characterize the long-term safety and effectiveness of the ...
Microinvasive glaucoma surgery (MIGS) has revolutionized the options available to patients with mild to moderate glaucoma. Most MIGS procedures are performed in conjunction with cataract extraction ...
Optometrist Dr. David Kordish often talks to patients about glaucoma and cataracts in doing general eye care. Now, he can see his patients with clearer vision and freedom from glaucoma medication ...
Over a 5-year period, the annual rate of progression in vision loss averaged 0.49 dB with surgery alone, compared with 0.26 dB with surgery plus a Schlemm's canal microstent (Hydrus). The results ...
Please provide your email address to receive an email when new articles are posted on . Eyes with primary angle-closure glaucoma that underwent phacoemulsification and implantation of two trabecular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results